So this is a very interesting question because we are seeing an evolution in the venture market where it's moving from generalist to specialist. And this is something that we saw in the US as well as the, as the venture market matures, the demand for specialist managers and specialist invents investor those up. It's just because if you are on a portfolio of 10 software companies, there's just so much more you'd learn about that's unique to software companies versus if you're on a software company and then on a biotech company and then on a deep tech company. It just kind of really dilutes the way that, that learning and the experience and the exposure. And so I think what I'm seeing starting to see in Europe more and more is the growth from a limited partner LP side. So LPs are people that invest in venture funds as well as, from entrepreneurs that are taking capital from investors or VCs. We're seeing a higher and higher demand of specialist investors, who, you know, sort of want folks that understand this. And specialist fund management is actually paramount in areas like biotech, to the returns of those funds.